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The relative fitness of drug-resistant versus susceptible bacteria in an environ-
ment dictates resistance prevalence. Estimates for the relative fitness of
resistant Mycobacterium tuberculosis (Mtb) strains are highly heterogeneous
and mostly derived from in vitro experiments. Measuring fitness in the field
allows us to determine how the environment influences the spread of resist-
ance. We designed a household structured, stochastic mathematical model
to estimate the fitness costs associated with multidrug resistance (MDR)
carriage in Mtb in Lima, Peru during 2010–2013. By fitting the model to
data from a large prospective cohort studyof TB disease in household contacts,
we estimated the fitness, relative to susceptible strains with a fitness of 1, of
MDR-Mtb to be 0.32 (95% credible interval: 0.15–0.62) or 0.38 (0.24–0.61), if
only transmission or progression to disease, respectively, was affected. The
relative fitness of MDR-Mtb increased to 0.56 (0.42–0.72) when the fitness
cost influenced both transmission and progression to disease equally. We
found the average relative fitness of MDR-Mtb circulating within households
in Lima, Peru during 2010–2013 to be significantly lower than concurrent
susceptible Mtb. If these fitness levels do not change, then existing TB control
programmes are likely to keep MDR-TB prevalence at current levels in
Lima, Peru.1. Background
Mycobacterium tuberculosis (Mtb) is a highly prevalent bacterium, thought to
infect just under a quarter of the world’s population [1]. Treatment of tubercu-
losis (TB) disease is not simple and drug-susceptible tuberculosis (DS-TB)
requires a multiple-drug regimen taken for at least six months [2]. Multidrug-
resistant tuberculosis (MDR-TB) treatment regimens are significantly longer,
cause serious side effects and are very expensive [3]. While currently 5% of
all TB cases globally are estimated to be MDR-TB [2], predicting the future
burden of DS- and MDR-TB is essential for TB control programmes.
One key parameter that determines the future prevalence of drug-resistant
TB is the relative fitness of drug-resistant Mtb strains when compared with
drug-susceptibleMtb strains [4–7]. Fitness is a complex, environment-dependent
trait that can be defined as the ability of a pathogen to survive, reproduce, be
Table 1. Fitted parameters with description, prior distributions, any differences by model structure and data used for ﬁtting. All parameters are ﬁtted to the TB
incidence date from the household (HH) study [17]. The three models have different assumptions around the effect of decreased ﬁtness, with f varying to be f1
(affects transmission rate) or f2 (affects progression to disease rate) (ﬁgure 1).
symbol parameter description
prior
distribution Model 1 Model 2 Model 3 data
fois external force of infection of DS-TB uniform
[0; 0:5]
/ DS-TB incidence in
MDR-TB index HH:
4264 [3916, 4338]
foir external force of infection of
MDR-TB
uniform
[0, 0:3]
/ MDR-TB incidence in
DS-TB index HH:
87 [13, 435]
f (f1, f2) relative ﬁtness of MDR-TB strains
compared to DS-TB strains,
which have a ﬁtness of 1
uniform
[0, 1]
0 , f1 , 1
f2 ¼ 1
f1 ¼ 1
0 , f2 , 1
f1 ¼ f2
0, f1 , 1
MDR-TB incidence in
MDR-TB index HH:
2112 [1646, 2358]
bs per capita transmission rate of
DS-TB within households
uniform
[90, 140]
/ DS-TB incidence in
DS-TB index HH:
4264 [3916, 4338]
br per capita transmission rate of
MDR-TB within households
calculated from other ﬁtted parameters: br ¼ f1bs
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2transmitted and cause secondary cases of disease. These abil-
ities are affected by multiple environmental factors such as a
host’s genetics, the current TB treatment regimen and other
risk factors for transmission, which are all time-varying. The
importance of this parameter has been highlighted by several
mathematical models which show how even small changes
in its value can predict widely varying future levels of MDR-
TB burden [4–6,8,9]. Thus, gaining environment-dependent,
accurate estimates of fitness is of critical importance.
WithinMtb, it has been shown that the appearance of drug
resistance (MDR) mutations affects fitness [10–12]. These pre-
vious studies have shown that resistant Mtb is, usually, less
fit than susceptible Mtb under a range of fitness definitions:
either by demonstrating a lower growth rate in vitro (e.g.
[13]), less progression to disease after inoculation in guinea
pigs (e.g. [14]) or a lower chance of causing secondary cases
of disease (e.g. [12,15]). The latter definition is important for
epidemiological predictions of burden, while the first provides
the potential underlying biological cause. The epidemiological
fitness of an Mtb strain can be split into an ability to (1) cause
secondary infections (transmission) and (2) cause subsequent
active disease (progression). For example, resistant Mtb may
be transmitted equally, but subsequent disease rates in those
infected may be lower or less severe. For Mtb this split is
especially pertinent due to the importance of the latent,
non-infectious stage of disease.
Alsohighly important forMtb is the spatial locationof trans-
mission [16]. Few studies have considered the critical influence
of household structure on transmission of Mtb. To our knowl-
edge, no studies have considered the spread of drug-resistant
tuberculosis in the context of a household-structured stochastic
mathematical model.
The difference in definitions of fitness and corresponding
experimental data makes translation from data analysis to pre-
dictive mathematical modelling difficult. Here, we tackle this
problem by fitting a mathematical model to a detailed dataset
on the transmission of Mtb strains collected in a large cohortstudy of households undertaken in Lima, Peru between 2010
and 2013 [17]. We derive estimates of fitness in this specific
setting with different fitness definitions (either effects on trans-
mission and/or progression to disease) and test the robustness
of these estimates under a range of assumptions. These par-
ameters will allow for better predictions of future MDR-TB
levels and an improved understanding of MDR-TB spread.2. Material and methods
2.1. Data
The details of the underlying study and participants can be found
in [17]. Briefly, 213 and 487 households were recruited with an
index case of diagnosed MDR- or DS-TB, respectively, during
2010–2013. Households were followed up for variable periods of
time up to a maximum of 3 years (electronic supplementary
material, figure S1). During the study households were visited
every six months, and household contacts were monitored for
TB disease. It was found that 35/1055 (3.32%, 95% CI [2.32,
0.4.58]), of the MDR-TB contacts, and 114/2356 (4.84%, 95% CI
[4.01, 5.78]), of the DS-TB contacts developed TB disease,
suggesting that DS-TB has higher fitness. Therewere no significant
differences between cohorts by HIV status, age, gender or house-
hold size [17].
The specific data used to calibrate the model were (i) the inci-
dence of MDR-TB and (ii) DS-TB in households with an index
DS-TB case and (iii) the incidence of MDR-TB and (iv) DS-TB
in households with an index MDR-TB case (table 1). The percen-
tages of incident cases with resistance profiles matching the
index was used to multiply the incidence levels accordingly.
2.2. Model structure
The mathematical model was a standard two-strain dynamic TB
model (figure 1), with transmission modelled at the level of
the household. A Gillespie stochastic simulation algorithm in
R [18] was developed using the R package ‘GillespieSSA’ [19].
Using a stochastic transmission model was important as the
uninfected
susceptible resistant
transmission
(primary reinfection (slow )fast
progression/reactivation
)
acquisition of resistance treatment/natural cure
LS LFS
pf f2pf
LR
AR
AR
AS
AS
LFR
fois + bs/h f1bs/h + foir
bs fbs
foi
r
fois
Figure 1. A standard natural history, transmission model for two strains (susceptible and resistant) of Mtb was used (diagram on the left). Uninfected people
become infected at a rate dependent on the number of active cases (dynamic transmission). Once infected, the majority of people (85%) are assumed to
enter a latent slow (LS/LR) state. The remainder enter a rapid progression (latent fast, LFS/LFR) state which has a higher rate of progression to active disease
(AS/AR). Resistance mutations are acquired during active disease. Those with active disease recover to the latent slow state via treatment or natural cure. The fitness
cost to resistance is assumed to affect the rate of transmission ( f1) or the rate at which those latently infected with MDR-TB progress to active disease ( f2). Only the
effect on primary transmission of f1 is highlighted here, but reinfection is also affected. f1 and f2 are set at 1 or allowed to vary between 0 and 1 in the three
separate models: f1 in Model 1, f2 in Model 2, and both f1 and f2 in Model 3. The four estimated parameters (shown in the diagram on the right) were rates of
internal transmission (bs, f ) and the external forces of infection (fois, foir). (Online version in colour.)
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3model was implemented independently in households where the
small populations mean stochastic effects are highly important.
The size of the household varied, with household size sample
from data on the distribution in the original household cohort
study [17]. We assumed that saturation of transmission could
occur and hence scaled our transmission rate by the size of the
household (number of people), assuming households have the
same ventilation level (or at least that this did not vary by index
case Mtb resistance status) and within-household homogeneous
mixing [20]. This assumption of frequency-dependent trans-
mission means that, in households with more people, household
members are assumed to have lower individual chance of infec-
tion from an active disease case than in smaller households,
due to decreased exposure. This has been observed for another
airborne pathogen, influenza [21] and was explored in sensi-
tivity analysis where we also considered density-dependent
transmission. All natural history parameters were taken from
the literature and are listed in table 2, and the dynamics
explained in the legend to figure 1.
Four parameters were estimated from the data (table 1 and
figure 1): (1) the per capita transmission rate of DS-TB within
households (bs), (2) the relative fitness of MDR-Mtb strains
versus DS-Mtb strains (f ) expressed as an effect on transmission
or progression or both, and the external (to households) force of
infection (foi) of (3) DS-TB fois and (4) MDR-TB foir.
Our main outcome was the impact of resistance on transmission
rates, but we also explored the impact on an approximate effective
reproduction number (see the electronic supplementary material).2.3. Three model formulations
Resistant strains were allowed to have an equal or lower fitness
relative to susceptible strains. The mechanisms behind this
reduction were estimated to affect two different rates: the trans-
mission rate, the rate of progression to disease, or both (figure 1).
We assumed that the fitness of the resistant strains could not riseabove that of susceptible strains due to the data from the house-
hold cohort [17]. Model 1 (transmission fitness cost model)
assumed that fitness costs directly affected the number of second-
ary infections by reducing the transmission parameter for
MDR-Mtb (0, f1, 1, f2 ¼ 1, figure 1). This is the standard
assumption for the effect of resistance on fitness for transmission
dynamic models of Mtb [6,9,38] and other pathogens [39]. Model
2 (progression fitness cost model) assumed that although MDR-
TB transmission occurred at the same rate as DS-TB, there is a
fitness cost to progression to disease (f1 ¼ 1, 0, f2, 1, figure 1).
Model 3 assumed that there was a fitness cost to both transmission
and progression, and that the cost was the same for both processes
(0, f1 ¼ f2, 1, figure 1). We could not explore a model with fit-
ness affecting both processes at differing levels as we did not
have data on levels of infection. Without these data, a model
with high transmission fitness cost but low progression cost
would be equally as likely as a model with a low transmission
fitness cost but a high progression cost and hence would be unin-
formative. Note that fixing either f1 or f2 equal to one is the same as
ignoring this parameter altogether and leaving the multiplied rate
at its background level as they are both scalar constant parameters
with no units.2.4. Model simulation
The model initially sampled 700 household sizes (with replace-
ment) from the exact distribution of household sizes in the trial
[22]. Initial numbers of people with latent infection were sampled
from a normal distribution generated by data from the literature
[2,40] (see the electronic supplementary material). The model
was then simulated for 10 years with an MCMC sampled set of
the four unknown parameters (pre-study period), capturing trans-
mission within the household prior to enrolment in the household
study. A random time point from this 10-year period in which
there was at least one active case with the same sensitivity as the
initial case in the household (i.e. DS-TB or MDR-TB) was taken
Table 2. Parameter values with description and baseline values. All prior distributions were uniform.
symbol parameter description
baseline
value
prior
distribution notes and references
Nr number of households with MDR-TB index case 213 / [22]
Ns number of households with DS-TB index case 487 / [22]
h household size 2–15 / [17]
p proportion of (re-)infected individuals who
progress to the ‘latent fast’ state
0.15 0.08–0.25 [23–25]
x protection from developing active TB upon
reinfection
0.35 0.25–0.45 [23,26–29]
f rate of reactivation among those latently
infected per year
1.13  1024 1–31024 [23,26,27,29–31]
1 probability of acquiring new drug resistance during
treatment
0.008 0.005–0.01 [32]
d proportion of new active cases which directly
become infectious
0.5 0.25–0.75 [23,29,33,34]
m background death rate 1/77 ¼ 0.013 0.012–0.014 inverse of average life expectancy
in Peru [35]
mA additional death rate of those actively infected and
infectious per year
0.26 0.2–0.4 [23]
N annual rate of natural cure for TB cases
(returns to latent state)
0.2 0.15–0.25 [23]
vs proportion of DS-TB active cases detected and
treated per year
0.8; 2 0.5–0.95 for 2012 [2] for pre-study; in study:
screen every 6 months
vr proportion of MDR-TB active cases detected and
treated per year
0.64; 2 0.2–0.9 79% of the above 80% (vs) found that
received DST in 2012 [36]; in study:
screen every 6 months
(1 – ks) proportion of DS-TB active cases started on
treatment that are successfully cured
0.74 0.5–0.9 [36,37] (for midpoint of study)
(1 – kr) proportion of MDR-TB active cases started on
treatment that are successfully cured
0.6 0.2–0.9 for 2012 [2]
pf progression rate of latent fast individuals
to active disease
0.2 0.1–0.9 duration of fast latency period of
5 years [27]
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4to be the time the household entered the study and the active index
casewas detected. This allows for simulation of changes in latency
in the household and provides initial conditions dependent upon
each parameter sample.
The above randomly chosen time point of entry to the study
was taken to be the initial conditions for the simulation of the
model that was fitted to the household study [17] (study period).
The same values of the four unknown parameters were used as
in the pre-study period and the simulation time for each household
was randomly sampled (with replacement) from the exact distri-
bution of follow-up times in the study (electronic supplementary
material, figure S1). The only parameter that changed, to match
the altered patient care in the study, was the case detection rate
which increased for the study period from the WHO estimates to
a screen occurring every six months (table 2).
The TB incidence from the model was calculated by deter-
mining the total number of new cases of active TB in all 700
households over the follow-up time, and dividing this by the
total number of follow-up years in these households. The total
number of follow-up years was a product of the number ofhousehold members and the follow-up time for the household,
taking into account any deaths over this time. We assumed
that none left the households other than by death (natural or
due to TB). Time with active disease was included in the
follow-up. For a detailed overview of the process see electronic
supplementary material, figure S2.
2.5. Model fitting
Approximate Bayesian computation (ABC) was paired with
Markov chain Monte Carlo (MCMC) methods to estimate the
four unknown parameters [41]. All other parameters were kept
fixed at their baseline value (table 2). The summary statistic
used was the TB incidence from the model falling within the
95% CI for all four TB incidence measures from the data. Uniform
priors were assumed for all four parameters (table 1).
To estimate the standard deviation required for the MCMC for
the four unknown parameters, Latin hypercube sampling (LHS)
from the prior ranges was initially used (Stage A, electronic sup-
plementary material). The empirical standard deviation from
01000
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Figure 2. Model fits. Black dots represent the Model 1 output that matches with the data shown in ranges for each type of household (HH). See electronic
supplementary material, figures S3 and S4 for equivalent plots for Model 2 and 3. (Online version in colour.)
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5the accepted fits was then used as the proposal distribution of a
Metropolis–Hastings MCMC sampler (Stage B), used to estimate
posterior probabilities of the parameters.
We used the generated trajectories to consider the probability
of remaining free of tuberculosis from the model output and
compared the trends to the data (fig. 2 from [17]).
2.6. Scenario analysis
A scenario analysis was used to explore the sensitivity of
Model 1 results to key natural history parameters. Firstly, we
changed the initial proportion of the population latently
infected with MDR-Mtb from 2% to 10%.
A full sensitivity analysis of the parameters kept fixed in the
model fits was not possible due to limitations imposed by compu-
tation time. Instead, to determine which further scenarios to
explore, we determined the parameters most correlated with TB
incidence in our model, and hence likely to have the biggest
impact on our model fit and parameter estimates. To determine
these parameters, we used LHS to choose 10 000 parameter sets
from (uniform) prior distributions for all parameters (table 2).
We then ran Model 1 with these 10 000 parameter sets and
determined theparameters thatwere statistically significantly corre-
latedwith anyof the fourTB incidence outputs (Kendall correlation,
p, 0.01). These parameters were then used to design two scen-
arios—one with a combination of these parameters at their prior
values which gave highest TB incidence and the combination
which gave the lowest TB incidence.
We also increased our 10-year initial run-in period for the popu-
lation to 30 years and explored the impact on the estimates.
Furthermore, we explored removing the assumption of saturating
household transmission (per capita transmission rate was then not
dependent onhousehold size, i.e. density-dependent transmission).
All code is available online [42].3. Results
3.1. Fit to the data
Model structures 1–3 could all replicate the data from the
household study (figure 2). The MCMC trace and density
plots of the posterior distributions are shown in the electronic
supplementary material.3.2. Parameter estimates
The estimates of the external foi for DS- and MDR-TB were
similar across the three models (table 3 and figure 3). The per
capita transmission rate of DS-TB within households was also
similar across the three models. The relative fitness of MDR-
Mtb was similar for Model 1 and 2, but increased in Model 3,
as might be expected as in this third model the reduction in fit-
ness is applied to two rates. For Model 1, that is assuming a
resistance phenotype affects transmission, the relative fitness
of MDR-Mtb was estimated to be 0.32 (median, 95% CI:
0.15–0.62) versus DS-Mtb with a fitness of 1. In Model 2,
where a resistance phenotype affected disease progression, a
similar relative fitness was estimated: 0.38 (0.24–0.61). If both
rates were affected, then the relative fitness of MDR-Mtb was
estimated to be 0.56 (0.42–0.72) (table 3 and figure 3).
Comparing the external foi for DS- versus MDR-TB,
we found that the ratio of the two was around 0.5 (median
estimate 0.45/0.58/0.68 from the three models). This single
value for the external foi represents a complex set of pro-
cesses (contact patterns, length of infectiousness etc.) and
hence cannot be used to determine relative fitness. However,
the ratio is in the range that supports our estimates of the rela-
tive fitness from the internal household model. The ratio of an
approximate effective reproduction number for MDR- and
DS-TB also supported our main results (see the electronic
supplementary material).
3.3. Probability of remaining free from tuberculosis
We explored the probability of remaining free from tuberculo-
sis as was presented from the original study (fig. 2 in [17]).
By comparison we had highly similar dynamics to the study
(see electronic supplementary material, figure S5).
3.4. Scenario analysis
Our five scenarios gave very similar estimates for the relative fit-
ness of MDR-Mtb (a range of medians from 0.27–0.34;
electronic supplementary material). This suggests that the esti-
mates of relative fitness are robust to: increasing the initial
proportion of households that were initially infected with
fois foir f
1 2 3 1 2 3 1 2 3 1 2 3
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Figure 3. Fitted parameters from each model. The units for the y-axis of the corresponding plots are: for the external forces of infection ( fois and foir) proportion
infected per year, for the relative fitness ( f ) there are no units and for the per capita transmission rate (beta) the units are effective contact rate per year. Model 1
assumes a transmission cost to resistance, Model 2 a disease progression cost and Model 3 assumes an effect on both. (Online version in colour.)
Table 3. Parameter estimates for the median and 95% credible intervals of the four unknown parameters from 50 000 MCMC iterations with a burn-in of
10 000 iterations. The ﬁtness cost to resistance is assumed to affect transmission in Model 1, progression to active disease in Model 2, and both transmission
and progression in Model 3.
Model fois foir b F
1 0.22 (0.03–0.49) 0.10 (0.01–0.26) 74.70 (54.80–97.60) 0.32 (0.15–0.62)
2 0.26 (0.05–0.48) 0.15 (0.01–0.29) 75.08 (56.85–96.30) 0.38 (0.24–0.61)
3 0.22 (0.05–0.46) 0.15 (0.01–0.29) 76.45 (58.60–95.42) 0.56 (0.42–0.72)
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6latent MDR-Mtb from 2% to 10% (in the pre-study), setting TB
incidence to high or low levels (see the electronic supplemen-
tary material for parameter details), extending the initial
run-in period from 10 to 30 years; or removing the saturation
of transmission within households.4. Discussion
Our results suggest that the average relative fitness of
MDR-Mtb strains circulating in households in Lima, Peru in
2010–2013was substantially lower than that of drug-susceptible
strains (approx. 40–70% reduction). When a resistance
phenotype was assumed to affect both transmission and pro-
gression to disease rates, then the relative fitness of MDR-TB
strains was approximately 60%.
The strengths of this study are that we were able to fit a
stochastic household-level model to detailed location-specific
data, accounting for accurate distributions of both household
size and study follow-up time. We were also able to differen-
tiate between internal and external transmission, matching
the resistance typing data from the household study [17].
Moreover, our transmission rate estimates account for the
longer infectiousness of MDR-TB cases (due to delays in
diagnosis and treatment initiation etc.). This model and its
MCMC fitting algorithm can be applied to other settings
and then used as the basis for predictions of future levels of
DS- and MDR-TB. In particular, this novel way of estimating
fitness costs, by fitting dynamic transmission models toresistance-specific incidence data could be used for other
TB-prevalent settings or for other bacteria. Furthermore, the
estimates given can be directly translated into dynamic trans-
mission models for prediction while previous estimates,
for example, of differences in growth rates have less clear
epidemiological translations.
Our modelling analysis is limited by the assumption of
homogeneity of both hosts and strains. The characteristics
of the DS- and MDR-TB contacts under consideration in the
underlying household study were highly similar [17]. Thus,
as our estimate is of a relative fitness, we believe that includ-
ing host differences in our model may have had little effect on
our relative results. Strain heterogeneities, however, mean
that our result is (potentially) an average across many differ-
ent drug-resistant strains. It is known that differences in
resistance and compensatory mutation combinations result
in a diversity in fitness across strains [13]. This diversity is
highly important for predictions of MDR-TB levels in the
future [43]. Our estimate must therefore be taken as a popu-
lation average in Lima, at a certain time and indicative of the
mean fitness rather than an indicator of the range of potential
fitness in the population. If one highly fit MDR-TB strain
were to emerge (or were already present), then future preva-
lence predictions based on our (mean) estimate could be an
underestimate. We fitted the model to data with confidence
intervals that were derived without fully accounting for the
dependency of infection between household members.
Improving methods for robust approximation of parameters
rsif.royalsocietypublishing.org
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7from mechanistic models that take full account of such
dependencies is an important active area of research [44],
and will improve future studies of this kind.
Our Model 1, where a transmission effect is assumed, is
the most similar to previous models of MDR-TB transmission
[6,9,38]. Reductions in transmission could arise from many
factors including differences in location of infection (pulmon-
ary versus non-pulmonary), a different interaction with the
basic immune system or different aerosolization levels. How-
ever, our MDR-TB fitness predictions are at the lower end of
the range seen previously [10]. This may reflect the situation
in Peru where there is a strong tuberculosis control infrastruc-
ture with a well-developed MDR-TB treatment programme
and a growing economy. These two factors may have com-
bined to limit the spread of MDR-TB and hence prevent the
adaptation of MDR-TB to a higher fitness. At the bacterial
level, compensatory fitness mutations that could influence
the ability of drug-resistant Mtb strains to spread may not
have emerged or not been allowed to spread. Calibrating the
model to other settings would help clarify this issue. Alterna-
tively, it may be that our estimates are providing, for the first
time, a better direct translation of fitness from epidemiological
data to a transmission model parametrization.
There is a paucity of evidence for whether differences in TB
disease prevalence in general are due to infection or pro-
gression to disease [45]. In particular, for resistant strains it is
unclear where the effect of becoming resistant should be
applied in the natural history of tuberculosis infection. Both
Snider and Teixeira [46,47] demonstrated similar levels of
tuberculin skin test (TST) conversion among MDR- and
DS-TB household contacts but lower levels of disease in con-
tacts of those with MDR-TB. This was also seen in a recent
study in children [48], while a higher prevalence of TSTpositiv-
ity was found in household contacts of MDR-TB patients than
contacts of newly diagnosed TB patients in Viet Nam [49]. This
evidence combines to suggest that the fitness cost to resistance,
if any, was to be observed on the progression to disease. We
make this assumption in our Model 2, where the hypothesis
is that those with active TB disease, whether due to resistant
or susceptible bacteria, have a similar bacterial load and
hence ability to transmit successfully. However, once success-
fully established in a new host, resistant bacteria may be less
able to combat the immune system and establish a disease
state. This has been assumed in a previous model of HIV and
MDR-TB interaction [50].
Previous models have assumed that resistant strains
could become more fit (i.e. have a relative fitness greater
than 1), while we capped the relative fitness of the resistant
strains at 1, due to the data from previous studies and the lit-
erature [13,51]. Our posterior parameter distributions for the
estimated relative fitness parameter (reflected in the 95% CIfor f; see the electronic supplementary material) suggest
that this is a valid assumption for the resistant strains circu-
lating at this time in Lima. Importantly, all our estimates are
of ‘relative’ fitness, and therefore should be robust to changes
in natural history assumptions as these would affect both
drug-susceptible and -resistant strain transmission.
Future work will include adding details on host and strain
heterogeneity to themodel. Data collection of strain heterogen-
eity along with active contact tracing and an understanding of
where and from whom transmission occurs would drastically
improve our understanding of fitness and hence improve esti-
mates of future MDR-TB levels. Exploring the external
infection methods and potential changes in this foi over time
(i.e. making it dynamic as in [52]) would allow for models
that can predict levels of MDR-TB in Lima. Future predictive
transmission modelling using our relative fitness estimates
are likely to suggest that if treatment objectives are maintained
and this fitnessmeasure remains constant,MDR-TB prevalence
will remain under control in Lima in the short term.
In conclusion, we find the fitness cost of MDR in Mtb in
Lima, Peru to be substantial. Importantly, this paper provides
direct transmission model estimates, using a novel method, of
the relative fitness levels of drug-resistantMtb strains. If these
fitness levels do not change, then the existing TB control pro-
grammes are likely to keep MDR-TB prevalence at their
current levels in Lima, Peru. These estimates now need to
be gained for Mtb in other settings and the values used in
models to explore future global burden.
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